Mast Group Ltd
Darrell Johnston is a seasoned professional in the field of Quality Assurance and Regulatory Affairs, currently serving as a Senior Quality Assurance & Regulatory Affairs Specialist at Mast Group Ltd since October 2023. With a robust background that includes roles such as Quality Assurance Manager at Neogen EMEA and EQA Lead/Senior Biomedical Scientist at The Walton Centre NHS Foundation Trust, Darrell has demonstrated expertise in managing quality systems and compliance, leading multi-department projects, and conducting comprehensive audits to enhance operational efficiency. Previous experiences include positions at notable healthcare organizations, where Darrell contributed to the successful implementation of accreditation processes and trained teams in quality management. Darrell holds a Master of Science in Biomedical Sciences from Ulster University and a Bachelor of Science in Biomedical Sciences from the University of Hertfordshire.
This person is not in any teams
This person is not in any offices
Mast Group Ltd
1 followers
Mast Group Ltd is a UK based leading independent European manufacturer and supplier of clinical diagnostic products. Established in Liverpool in 1957, Mast Group has grown into a multinational company exporting globally. The corporate headquarters Mast Group Ltd are based in Bootle and has subsidiary companies in Reinfeld (Mast Diagnostica GmbH) and Amiens, France (Mast Diagnostic). Mast Group were among the first companies to commercialise the antibiotic disc, and continue to work with major pharmaceutical companies worldwide in the development of new and exciting products. Mast Group focuses on the susceptibility, identification and resistance along with offering molecular and immunochemistry solutions for the IVD market. This is achieved through the investment in personnel, R&D and infrastructure, including state of the art manufacturing facilities in Merseyside. This enables Mast Group to provide tools to aid in the diagnosis of clinical disease, from pioneering antibiotic susceptibility testing to novel molecular solutions, Mast Group continues to develop products for the ever changing IVD market, creating solutions to support clinical diagnosis today and into the future.